Related Experiment Video

Updated: Aug 13, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Blood cholesterol screening influence of fasting state on cholesterol results and management decisions

S R Craig1, R V Amin, D W Russell

  • 1University of Iowa-Des Moines Internal Medicine Residency Program, Iowa Methodist Medical Center, Des Moines, USA. craigs@ihs.org

Insights

Screening adults for total and high-density lipoprotein (HDL) cholesterol using nonfasting blood tests is appropriate for primary prevention of heart disease. Nonfasting results closely align with fasting tests, ensuring accurate risk assessment.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Chemistry

Background:

  • Accurate cholesterol assessment is crucial for primary prevention of coronary heart disease (CHD).
  • Fasting blood tests are traditionally used for lipid profiling, but nonfasting tests may offer greater convenience.
  • Understanding the comparability of fasting versus nonfasting lipid levels is essential for clinical practice guidelines.

Purpose of the Study:

  • To compare fasting and nonfasting total cholesterol and high-density lipoprotein (HDL) cholesterol values in adults.
  • To evaluate the concordance of CHD risk classification based on nonfasting versus fasting lipid profiles.

Main Methods:

  • A cross-sectional study involving 181 adult patients at a community hospital internal medicine clinic.
  • Total and HDL cholesterol were measured twice for each patient within 7 days: once nonfasting and once after a minimum 12-hour fast.
  • Patients were categorized into desirable, borderline-high, and high cholesterol risk groups based on both fasting and nonfasting results.

Main Results:

  • Nonfasting and fasting total cholesterol showed small, statistically insignificant clinical differences.
  • Nonfasting HDL cholesterol levels were comparable to fasting HDL levels.
  • Classification agreement for desirable and high cholesterol groups was high (86.7% and 89.5%).
  • Agreement for the borderline-high HDL cholesterol group, critical for management decisions, was 95% between fasting and nonfasting tests.
  • A small fraction of patients were reclassified to lower-risk groups by nonfasting assessments, potentially impacting monitoring intensity.

Conclusions:

  • Nonfasting screening for total and HDL cholesterol is suitable for guiding primary prevention decisions for CHD.
  • The study supports the clinical utility of nonfasting lipid profiles in routine adult health assessments.
  • Findings were consistent across subgroups, including older men and women.
Abstract

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...